What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Schneider, P ^a,b   Dubus, I ^a   Gouel, F ^a   Legrand, E ^a   Vannier, J P ^a,b   Vasse, M ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1; THALIDOMIDE; VASCULOTROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANGIOGENESIS; BONE MARROW BIOPSY; CANCER REGRESSION; CANCER RELAPSE; CHILDHOOD LEUKEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOXIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 84855259894     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/274628     Document Type: Review

References (51)

1. Roskoski R. Jr., Vascular endothelial growth factor (VEGF) signaling in tumor progression Critical Reviews in Oncology/Hematology 2007 62 3 179 213
2. Cristofaro B., Emanueli C., Possible novel targets for therapeutic angiogenesis Current Opinion in Pharmacology 2009 9 2 102 108
3. Murakami M., Simons M., Fibroblast growth factor regulation of neovascularization Current Opinion in Hematology 2008 15 3 215 220 (Pubitemid 351507574)
4. Hu B., Cheng S. Y., Angiopoietin-2: development of inhibitors for cancer therapy Current Oncology Reports 2009 11 2 111 116
5. Ribatti D., Conconi M. T., Nussdorfer G. G., Nonclassic endogenous regulators of angiogenesis Pharmacological Reviews 2007 59 2 185 205 (Pubitemid 46855439)
6. Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine 1995 1 1 27 31
7. Folkman J., Tumor angiogenesis: therapeutic implications New England Journal of Medicine 1971 285 21 1182 1186
8. Moroni E., Dell'Era P., Rusnati M., Presta M., Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors Journal of Hematotherapy and Stem Cell Research 2002 11 1 19 32 (Pubitemid 34163768)
9. Ribatti D., Vacca A., Rusnati M., Presta M., The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies Cytokine and Growth Factor Reviews 2007 18 3-4 327 334 (Pubitemid 46891290)
10. Aguayo A., Estey E., Kantarjian H., Mansouri T., Gidel C., Keating M., Giles F., Estrov Z., Barlogie B., Albitar M., Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 1999 94 11 3717 3721
11. Dong X., Han Z. C., Yang R., Angiogenesis and antiangiogenic therapy in hematologic malignancies Critical Reviews in Oncology/Hematology 2007 62 2 105 118 (Pubitemid 46584811)
12. Karjalainen K., Jaalouk D. E., Bueso-Ramos C. E., Zurita A. J., Kuniyasu A., Eckhardt B. L., Marini F. C., Lichtiger B., O'Brien S., Kantarjian H. M., Cortes J. E., Koivunen E., Arap W., Pasqualini R., Targeting neuropilin-1 in human leukemia and lymphoma Blood 2011 117 3 920 927
13. Poyer F., Coquerel B., Pegahi R., Cazin L., Norris V., Vannier J. P., Lamacz M., Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia Leukemia Research 2009 33 3 407 417
14. Aguayo A., Kantarjian H., Manshouri T., Gidel C., Estey E., Thomas D., Koller C., Estrov Z., O'Brien S., Keating M., Freireich E., Albitar M., Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Blood 2000 96 6 2240 2245
15. Pruneri G., Bertolini F., Soligo D., Carboni N., Cortelezzi A., Ferrucci P. F., Buffa R., Lambertenghi-Deliliers G., Pezzella F., Angiogenesis in myelodysplastic syndromes British Journal of Cancer 1999 81 8 1398 1401
16. Salven P., Orpana A., Teerenhovi L., Joensuu H., Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients Blood 2000 96 12 3712 3718
17. Faderl S., Do K. A., Johnson M. M., Keating M., O'Brien S., Jilani I., Ferrajoli A., Ravandi-Kashani F., Aguilar C., Dey A., Thomas D. A., Giles F. J., Kantarjian H. M., Albitar M., Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia Blood 2005 106 13 4303 4307 (Pubitemid 41775940)
18. Pul M. A., Gullmann C., Dennis D., McMahon C., Jeffers M., Smith O. P., Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance British Journal of Haematology 2002 118 4 991 998 (Pubitemid 35025961)
19. Yetgin S., Yenicesu I., etin M., Tuncer M., Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia Leukemia and Lymphoma 2001 42 1-2 83 88 (Pubitemid 32700925)
20. Perez-Atayde A. R., Sallan S. E., Tedrow U., Connors S., Allred E., Folkman J., Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia American Journal of Pathology 1997 150 3 815 821 (Pubitemid 27106153)
21. Daldrup-Link H. E., Henning T., Link T. M., MR imaging of therapy-induced changes of bone marrow European Radiology 2007 17 3 743 761
22. Frater J. L., Kay N. E., Goolsby C. L., Crawford S. E., Dewald G. W., Peterson L. C., Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence Diagnostic Pathology 2008 3 1, article no. 16
23. Ma L., Hollenberg M. D., Wallace J. L., Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist British Journal of Pharmacology 2001 134 4 701 704 (Pubitemid 33016140)
24. Koomagi R., Zintl F., Sauerbrey A., Volm M., Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction Clinical Cancer Research 2001 7 11 3381 3384 (Pubitemid 33069969)
25. Schneider P., Vasse M., Sbaa-Ketata E., Lenormand B., Hong L., Soria C., Vannier J. P., The growth of highly proliferative acute lymphoblastic leukemia may be independent of stroma and/or angiogenesis Leukemia 2001 15 7 1143 1145 (Pubitemid 32717290)
26. Schneider P., Vasse M., Legrand E., Callat M. P., Vannier J. P., Have urinary levels of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, a prognostic value in childhood acute lymphoblastic leukaemia British Journal of Haematology 2003 122 1 163 164 (Pubitemid 36819354)
27. Wellman S., Guschmann M., Griethe W., Eckert C., Stackelberg A., Lottaz C., Moderegger E., Einsiedel H. G., Eckardt K. U., Henze G., Seeger K., Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF Leukemia 2004 18 5 926 933 (Pubitemid 38714616)
28. Avramis I. A., Panosyan E. H., Dorey F., Holcenberg J. S., Avramis V. I., Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962 Clinical Cancer Research 2006 12 23 6978 6984 (Pubitemid 44974492)
29. Schneider P., Vasse M., Corbire C., Legrand E., Marie-Cardine A., Boquet C., Cazin L., Vannier J. P., Endostatin variations in childhood acute lymphoblastic leukaemia-Comparison with basic fibroblast growth factor and vascular endothelial growth factor Leukemia Research 2007 31 5 629 638 (Pubitemid 46560002)
30. Lyu C. J., Rha S. Y., Won S. C., Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia Yonsei Medical Journal 2007 48 2 171 175 (Pubitemid 46711745)
31. Stachel D., Albert M., Meilbeck R., Paulides M., Schmid I., Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia Oncology reports 2007 17 1 147 152
32. Werther K., Christensen I. J., Nielsen H. J., Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets Scandinavian Journal of Clinical and Laboratory Investigation 2002 62 5 343 350
33. Glenjen N., Mosevoll K. A., Bruserud Y., Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia International Journal of Cancer 2002 101 1 86 94 (Pubitemid 34833002)
34. Veiga J. P., Costa L. F., Sallan S. E., Nadler L. M., Cardoso A. A., Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival Experimental Hematology 2006 34 5 610 621
35. Wickstrm S. A., Alitalo K., Keski-Oja J., Endostatin signaling and regulation of endothelial cell-matrix interactions Advances in Cancer Research 2005 94 1 197 229 (Pubitemid 41202366)
36. Molica S., Cutrona G., Vitelli G., Mirabelli R., Molica M., Digiesi G., Ribatti D., Ferrarini M., Vacca A., Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia Leukemia Research 2007 31 11 1575 1578 (Pubitemid 47632791)
37. Norén-Nystrm U., Heyman M., Frisk P., Golovleva I., Sundstrm C., Porwit A., Roos G., Bergh A., Forestier E., Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome British Journal of Haematology 2009 146 5 521 530
38. Veiga J. P., Sallan S. E., Nadler L. M., Cardoso A. A., De novo angiogenesis confers a selective adventage to leukemic celles through contact-dependent maintenance of anti-apoptotic gene expression Blood 1999 94, abstract 658a
39. Klein G., Vellenga E., Fraaije M. W., Kamps W. A., De Bont E. S. J. M., The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia Critical Reviews in Oncology/Hematology 2004 50 2 87 100 (Pubitemid 38638736)
40. Schneider P., Costa O., Legrand E., Bigot D., Lecleire S., Grassi V., Jean-PierreVannier, Vasse M., In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia Leukemia Research 2010 34 1 24 31
41. Suminoe A., Matsuzaki A., Hattori H., Koga Y., Ishii E., Hara T., Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement Leukemia Research 2007 31 10 1437 1440 (Pubitemid 47212424)
42. Snow J. W., Abraham N., Ma M. C., Abbey N. W., Herndier B., Goldsmith M. A., Oxygen saturation in the bone marrow of healthy volunteers Blood 2002 99 1 394 (Pubitemid 34533016)
43. Fiegl M., Samudio I., Clise-Dwyer K., Burks J. K., Mnjoyan Z., Andreeff M., CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure Blood 2009 113 7 1504 1512
44. Yang R., Zhong C. H., Angiogenesis in hematologic malignancies and its clinical implications International Journal of Hematology 2002 75 3 246 256 (Pubitemid 43014055)
45. Bertolini F., Mingrone W., Alietti A., Ferrucci P. F., Cocorocchio E., Peccatori F., Cineri S., Mancuso P., Corsini C., Burlini A., Zucca E., Martinelli G., Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers Annals of Oncology 2001 12 7 987 990 (Pubitemid 32725774)
46. Karp J. E., Gojo I., Pili R., Gocke C. D., Greer J., Guo C., Qian D., Morris L., Tidwell M., Chen H., Zwiebel J., Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1- -D-arabinofuranosylcytosine, mitoxantrone, and bevacizumab Clinical Cancer Research 2004 10 11 3577 3585 (Pubitemid 38697590)
47. Bergers G., Hanahan D., Modes of resistance to anti-angiogenic therapy Nature Reviews Cancer 2008 8 8 592 603
48. Reikvam H., Hatfield K. J., Lassalle P., Olsnes Kittang A., Ersvr E., Bruserud Ø., Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release Expert Opinion on Investigational Drugs 2010 19 2 169 183
49. Petit I., Karajannis M. A., Vincent L., Young L., Butler J., Hooper A. T., Shido K., Steller H., Chaplin D. J., Feldman E., Rafii S., The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death Blood 2008 111 4 1951 1961 (Pubitemid 351451505)
50. Demacq C., Vasconcellos V. B., Izidoro-Toledo T. C., da Silva Silveira V., Canalle R., Queiroz R. G. D. P., Tone L. G., Tanus-Santos J. E., Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL) Clinica Chimica Acta 2010 411 17-18 1335 1340
51. Schliemann C., Bieker R., Thoennissen N., Gerss J., Liersch R., Kessler T., Bchner T., Berdel W. E., Mesters R. M., Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia Leukemia 2007 21 9 1901 1906 (Pubitemid 47299962)